Tangram Therapeutics is developing investigational treatments aimed at addressing the condition MASH (metabolic dysfunction-associated steatohepatitis).
1 report, 1 independent
Updated Sep 3
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Tangram Therapeutics is developing investigational treatments aimed at addressing the condition MASH (metabolic dysfunction-associated steatohepatitis).
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
mash
fast genome and metagenome distance estimation using MinHash
Nothing else this week.